We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Ion Beam Applications SA | EU:IBAB | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04 | -0.30% | 13.30 | 13.24 | 13.70 | 13.54 | 13.26 | 13.36 | 13,342 | 16:40:00 |
From Jun 2024 to Dec 2024
HY24 results webcast to take place on
Thursday, 29 August 2024 at 3pm CEST
Louvain-la-Neuve, Belgium, 1 August 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the half year 2024 on Thursday, 29 August 2024 at 7am CEST.
Conference Call Information
IBA’s management team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session.
The conference call will be held on Thursday, 29 August 2024 at 3pm CEST / 2pm BST / 9am EDT / 6am PDT as a Teams webinar and can be accessed via this link.
If you would like to join by phone only, please dial (Phone conference ID 533 540 829#)
Belgium: +32 2 890 97 20
UK: +44 20 3321 5200
NL: +31 20 708 6901
LU: +352 27 87 00 02
US: +1 347-991-7591
FR: +33 1 70 99 53 51
The presentation will be available on IBA’s investor relations website and on:
https://www.iba-worldwide.com/iba-half-year-2024-results-presentation-and-press-release shortly before the call.
To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.
For participants who do not have the Teams application installed, please follow the process described in this link to access the conference.
ENDS
About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
CONTACTS
Soumya Chandramouli
Chief Financial Officer
+32 10 475 890
Investorrelations@iba-group.com
Olivier Lechien
Corporate Communication Director
+32 10 475 890
communication@iba-group.com
ICR Consilium
Amber Fennell, Matthew Neal, Lucy Featherstone
+44 (0) 20 3709 5700
IBA@consilium-comms.com
Attachment
1 Year Ion Beam Applications Chart |
1 Month Ion Beam Applications Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
